Norway· NO-ID_E4CF8C4A-7703-4575-9AF2-C5CDCD087034
Sandomigran
A pizotifen product containing pizotifen malate, registered in Norway by Phoenix Labs. The same ATC class is registered in 7 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Pizotifen is registered in 7 of 19 countries.
Countries holding a registration under ATC N02CX01 (pizotifen), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 3 of them publish a price we can compare per daily dose
Pizotifen · ATC N02CX01
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Pizotifen Malate
- Manufacturer
- Phoenix Labs
- Country
- Norway (NO)
- ATC code
- N02CX01
- ATC class
- Pizotifen
- Defined daily dose
- 1.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_E4CF8C4A-7703-4575-9AF2-C5CDCD087034
- no_varenummer22660530
- gtin7612791041099
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N02CX01
Pizotifen, as other registers publish it.
- United KingdomPizotifen 1.5mg tabletsAlmus Pharmaceuticals Ltd
- United KingdomPizotifen 1.5mg tabletsMedihealth (Northern) Ltd
- United KingdomPizotifen 1.5mg tabletsPhoenix Healthcare Distribution Ltd
- United KingdomPizotifen 1.5mg tabletsKent Pharma (UK) Ltd
- United KingdomPizotifen 1.5mg tabletsAccord-UK Ltd
- United KingdomPizotifen 1.5mg tabletsRivopharm (UK) Ltd
- United KingdomPizotifen 1.5mg tabletsA A H Pharmaceuticals Ltd
- United KingdomPizotifen 1.5mg tabletsAlliance Healthcare (Distribution) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Sanmigran
- United Kingdom (Northern Ireland) · Pizotifen, Pizotifen Accord-Uk
- Netherlands · Sandomigran
- Slovakia · Sandomigran
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7364f39b-a5c0-46e5-a01f-9ba573c810f0 GET /v1/drugs/7364f39b-a5c0-46e5-a01f-9ba573c810f0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, drasjert",
"source": "fest",
"status": "A",
"atc_name": "Pizotifen",
"merkevare_id": "ID_E4CF8C4A-7703-4575-9AF2-C5CDCD087034",
"name_form_strength": "Sandomigran tab 0,5 mg",
"prescription_group": "C"
}See everything about pizotifen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.